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Abstract
Background: Cardiovascular disease (CVD) is the leading cause of death globally. However, many individuals are
unaware of their CVD risk factors. The objective of this systematic review is to determine the effectiveness of existing
intervention strategies to increase uptake of CVD risk factors screening.
Methods: A systematic search was conducted through Pubmed, CINAHL, EMBASE and Cochrane Central Register of
Controlled Trials. Additional articles were located through cross-checking of the references list and bibliography
citations of the included studies and previous review papers. We included intervention studies with controlled
or baseline comparison groups that were conducted in primary care practices or the community, targeted at
adult populations (randomized controlled trials, non-randomized trials with controlled groups and pre- and
post-intervention studies). The interventions were targeted either at individuals, communities, health care
professionals or the health-care system. The main outcome of interest was the relative risk (RR) of screening
uptake rates due to the intervention.
Results: We included 21 studies in the meta-analysis. The risk of bias for randomization was low to medium in
the randomized controlled trials, except for one, and high in the non-randomized trials. Two analyses were performed;
optimistic (using the highest effect sizes) and pessimistic (using the lowest effect sizes). Overall, interventions were
shown to increase the uptake of screening for CVD risk factors (RR 1.443; 95% CI 1.264 to 1.648 for pessimistic analysis
and RR 1.680; 95% CI 1.420 to 1.988 for optimistic analysis). Effective interventions that increased screening participation
included: use of physician reminders (RR ranged between 1.392; 95% CI 1.192 to 1.625, and 1.471; 95% CI 1.304 to 1.
660), use of dedicated personnel (RR ranged between 1.510; 95% CI 1.014 to 2.247, and 2.536; 95% CI 1.297 to 4.960)
and provision of financial incentives for screening (RR 1.462; 95% CI 1.068 to 2.000). Meta-regression analysis showed
that the effect of CVD risk factors screening uptake was not associated with study design, types of population
nor types of interventions.
Conclusions: Interventions using physician reminders, using dedicated personnel to deliver screening, and
provision of financial incentives were found to be effective in increasing CVD risk factors screening uptake.
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Background
A major challenge to the control of cardiovascular disease
(CVD) is the high prevalence of cardiovascular risk factors
such as hypertension, diabetes and obesity [1–3]. A
substantial proportion of the global population remain
unaware of their existing cardiovascular risk factors [4–6].
Modifiable risk factors for CVD account for 90% of the
risk of myocardial infarction, which indicates that CVD is
largely preventable [7]. Effective management strategies
such as lifestyle changes or pharmacotherapy are available
to modify these risk factors, which have been shown to
reduce CVD morbidity and mortality especially for those
at high risk [8–12]. Two cohort studies from Korea and
Japan reported that health screening for CVD was associ-
ated with lower rates of CVD, all-cause mortality, CVD
events and lower healthcare utilization and costs [13, 14].
There has been considerable debate regarding the use-
fulness of screening for CVD risk factors [15–19]. A sys-
tematic review by Krogsbøll found that general health
checks did not reduce morbidity or mortality of CVD
[20]. Others have argued that the results of this review
cannot be generalized because it included old studies
from an era when management was not as effective as
current treatment [21]. As the review also focused on
general health checks, the findings may differ from
health checks conducted for specific conditions such as
CVD and cancer [21–23].
Various strategies and interventions have been used
to increase individuals’ participation in CVD risk fac-
tors screening. Their effectiveness varied from study to
study, ranging from no benefit to an 80% increase in
the participation rate from baseline [24–27]. Jepson
et al. conducted a comprehensive systematic review to
examine factors associated with the uptake of screening
programmes and to assess the effectiveness of methods
used to increase uptake [28]. However, the majority of
the studies included in this review were related to can-
cer screening, with very limited studies on CVD risk
factors screening. To the best of our knowledge, there
has previously been no systematic review analyzing the
effectiveness of interventions used to increase uptake
rate of CVD risk factors screening amongst the general
population from primary care practices and the com-
munity. Previous systematic reviews have focused on
assessing the effectiveness of using community pharma-
cies as the site for CVD risk factors screening [29], the
evaluation of behavioural components used in the inter-
vention of screening programmes [30], and reviewing
screening approaches in primary care [31]. Therefore, the
objective of this study is to examine the literature to
determine the effectiveness of interventions used to
increase the uptake of CVD risk factors screening in
adult population from primary care practices and the
community.
Methods
The research question addressed in this systematic re-
view is as follows:
What is the effectiveness of interventions that aim to
increase the uptake of CVD risk factors screening?
Population: Adults aged 18 years and above
Intervention: Interventions that aim to increase
participation of individuals to screen for CVD risk
factors
Comparison: comparator groups with usual care
Outcome: uptake rate (participation rate by public or
patients or screening rate which was represented by the
tests performed by physicians)
Criteria for study selection
Types of studies
Studies on interventions that aimed to increase par-
ticipation of individuals to screen for CVD risk factors
were included. Study designs included randomized
controlled trials (RCTs), quasi-RCTs, non-randomized
trials with controlled group and studies which used
baseline data as the control group (pre- and post-
studies). Studies comparing different interventions
were excluded if there was no controlled or baseline
group.
Assessment for screening of CVD risk factors
The CVD risk factors screening included for assess-
ment in the review were measurements of blood pres-
sure (BP), weight, body mass index (BMI), waist
circumference (WC), glucose, lipids, total cardiovascu-
lar risk score and history taking regarding smoking,
physical activity, or nutritional intake. These CVD risk
factors screening could have been carried out in a pro-
gram specifically targeting CVD risk factors screening,
or as part of a program with other preventive services
such as cancer screening and vaccination.
Study population
The population for included studies involved those
individuals aged 18 years and above recruited from at-
tendees of primary care practices or the community. We
included studies with mixed populations with or without
known CVD and studies limited to populations without
known CVD.
Studies which targeted specific populations or condi-
tions such as safety screening for sports or exercise par-
ticipation, gestational diabetes or post partum screening,
familial hypercholesterolaemia and participants with a
defined condition such as mental disabilities or rheuma-
toid arthritis, were excluded.
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Types of interventions
All types of interventions or strategies to increase par-
ticipation of CVD risk factors screening were included,
regardless of whether they were targeted at individual,
community, health-care provider or health-care system
level.
Types of outcome measures
The CVD risk factors screening uptake was measured by
1) participants’ attendance rate for screening, or 2)
screening rate by health-care providers. We excluded
studies that only reported on the intention to participate
or physicians’ compliance with the prescription. In cases
where the studies had included screening for health con-
ditions other than CVD risk factors, we chose to report
only outcomes related to CVD risk factors.
Search methods
A systematic search was conducted using four electronic
databases: PubMed (12 June 2014), CINAHL (3 July
2014), EMBASE (10 July 2014), and Cochrane Central
Register of Controlled Trials (3 July 2014). Updates of
this search strategy were obtained from PubMed weekly
until August 2015 and no new study was identified that
fitted our inclusion criteria.
A mixture of medical subject headings (MeSH terms)
and free text was used for the concept of “cardiovascu-
lar”, “uptake” and “screening”. The search strategy for
PubMed is shown in Table 1. These search terms and
limits were modified accordingly for each individual
database, in order to meet its specification. Limits ap-
plied were English language and adult population. There
was no limit applied for the year of publication. Add-
itional articles were located through cross-checking of
reference lists and bibliography citations of the included
studies. This reference list and bibliography citations
included review papers. For these review papers, we
checked the reference lists to retrieve relevant studies.
Data collection and analysis
Study selection and data extraction
Two reviewers (ATC and NFMZ) screened the titles and
abstracts of the articles and conference proceedings. Full
papers were then retrieved for potentially eligible articles
and reviewed for relevance by ATC and NFMZ. An
article was included when there was agreement on the
fulfilment of the inclusion criteria. In circumstances
where there was a discrepancy, discussions with other
team members (SML and EMK) were held to reach a
consensus. When further details of the paper were
required, corresponding authors were contacted via
email; for example when full details of the numerator
and denominator of the screening rate were not avail-
able, or when there was uncertainty about the same data
being presented in more than one publication that de-
scribed a single study, to avoid problems of double
counting of subjects in the meta-analysis [27, 32–40].
Data were then extracted independently by two re-
viewers (ATC and NFMZ) from the included studies.
Relevant information extracted included author(s), year,
country of study, title, type of setting, type of screening
assessment, study design, study population characteris-
tics, type of intervention and the proportion of participa-
tion (numerators and denominators) in the intervention
and the controlled arm, which represented the CVD risk
factors screening uptake rate. Information on study de-
sign, study population characteristics, and types of inter-
vention were extracted to allow for meta-regression.
Assessment of quality
Appraisal of the quality of methodology of the included
studies was conducted using The Cochrane Collabora-
tion’s “Risk of bias” tool [41]. Each study was assessed
based on the features of selection bias, performance bias,
detection bias, attrition bias, reporting bias and other
potential sources of bias for quality of methodology [41].
The quality of descriptions of interventions in publica-
tions was assessed using the Template for Intervention
Description and Replication (TIDieR) checklist and
guide [42]. The TIDier checklist has 12 items to assess
the reproducibility of the intervention based on the de-
scription, which included items such as brief name, why,
what (materials), what (procedure), who provided, how,
where, when and how much, tailoring, modifications,
how well (planned), how well (actual) [42].
Data synthesis and analysis
In this review, two analyses were conducted. First, an
analysis was carried out on the overall effectiveness of
Table 1 Search strategy in PubMed
#1 Search (((((((("Hyperlipidemias"[Mesh]) OR "Cardiovascular Diseases"[Mesh])
OR "Hypertension"[Mesh]) OR "Diabetes Mellitus"[Mesh])) OR
((((((((((cardiovascular[Text Word]) OR coronary[Text Word]) OR stroke[Text
Word]) OR heart[Text Word]) OR family history[Text Word]) OR early
cardiovascular death[Text Word]) OR hyperlipidemias[Text Word]) OR
diabetes mellitus) OR hypertension)))
#2 Search ((((((((general practice[Text Word]) OR preventive health
service[Text Word]) OR health check*[Text Word]) OR mass screening[Text
Word]) OR opportunistic screening[Text Word])) OR (((((health check*) OR
"General Practice"[Mesh]) OR "Preventive Health Services"[Mesh]) OR "Mass
Screening"[Mesh])))) OR screening[Text Word]
#3 Search ((((((((("Patient Acceptance of Health Care"[Mesh]) OR "Patient
Participation"[Mesh]) OR "Consumer Participation"[Mesh]) OR "Refusal to
Participate"[Mesh]) OR uptak*))) OR (((((patient participation[Text Word])
OR consumer participation[Text Word]) OR uptak*[Text Word]) OR patient
acceptance of health care[Text Word]) OR refusal to participate[Text Word])))
OR participat*
#4 Search #1AND #2 AND #3
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screening uptake of the interventions compared with its
control. Second, subgroup analysis was done measuring
the effectiveness of screening uptake by study design
and type of intervention. Relative risk (RR) with 95%
confidence interval (95% CI) was performed for all sets
of comparisons. Data from relevant studies were pooled
using a random-effects model with OpenMetaAnalyst
software [43, 44]. A test of heterogeneity (Cochran’s Q
statistic) with reported p-value was performed and the
degree of inconsistency across studies was quantified
using I2 [45].
Meta-regression is a method used to explore hetero-
geneity seen in meta-analysis by examining differences
between studies by effect modifiers [46]. In this study,
meta-regression was performed in order to explore
whether the differences in study designs (RCT, Con-
trolled trial, pre- and post-studies), types of population
(no known CVD, mixed population of known and un-
known CVD) and types of intervention (physician re-
minder, patient invitation, using financial incentives,
using dedicated personnel and multifaceted approach)
could explain the heterogeneity. Random-effects meta-
regression was performed using OpenMetaAnalyst soft-
ware [43].
Some studies compared more than one type of inter-
vention with usual care [27, 47–49]. Each of these inter-
vention groups was analyzed independently and
compared with the group with usual care. For studies
with separate screening uptake rates for the different risk
factors, the outcome could be represented by any one of
these rates [27, 33, 50–57]. For example, the study by
Harari et al. reported the uptake rate for BP, cholesterol
and blood glucose separately [52]. In order to provide a
range of the effectiveness of such interventions, two
meta-analyses were performed; one pooling the highest
effect sizes of the uptake rate (hereon referred to as opti-
mistic) and the other pooling the lowest effect sizes of
the uptake rate (hereon referred to as pessimistic). In
studies that reported results of screening uptakes using
different time periods, we used the longest duration of
timeline in the analysis [48, 56].
Results
Literature retrieval process
The search strategy identified 21,307 citations from four
databases after removing duplicates. After screening the
titles and abstracts, 167 full papers were retrieved for as-
sessment for eligibility. Of these, 158 papers were ex-
cluded as they did not fulfill the inclusion criteria. The
reasons for exclusion included the age of the study popu-
lation, the absence of a controlled group, or the outcomes
were not related to screening uptake. One study published
three papers from data obtained at different periods
[32–34], and the most recent paper was included [33].
A total of 9 studies fulfilled the inclusion criteria and
were included [27, 33, 35, 36, 47, 54, 55, 58, 59]. For-
ward and backward searches of the reference lists and
bibliography citations of the 9 studies yielded an add-
itional 16 studies [37, 39, 48–53, 56, 57, 60–65] and re-
sulted in a total of 25 studies for qualitative synthesis.
We contacted authors of six studies which did not have
full details of the numerators and denominators of the
screening uptake rates required for meta-analysis. Two
authors provided the requested information [27, 37]
while authors of the other four studies were either not
contactable or stated that they no longer had access to
the data. These four studies [35, 36, 39, 65] were ex-
cluded, and the final number of studies included in the
meta-analysis was 21. Figure 1 illustrates the process of
study search and selection.
Study characteristics of the studies included
Among the 21 studies, ten were randomized or cluster
randomized controlled trials [27, 37, 47–52, 58, 60],
six were non-randomized trials with controlled group
[53–55, 59, 61, 62] and five were pre and post- studies
[33, 56, 57, 63, 64]. Eleven studies analyzed CVD risk
factors screening [33, 37, 47, 49, 53, 58–63] and 10
studies focused on multiple preventive services in-
cluding screening for cancer, vitamin B12, vaccination
promotion, and others [27, 48, 50–52, 54–57, 64]
(refer to Table 2). The follow-up period of these
studies ranged from 2 months to 3 years. Out of the
21 studies, eight were conducted in Europe (five in
the United Kingdom [50, 52, 53, 60, 61], one each in
the Netherlands [49], Denmark [59] and Sweden
[54]), seven in North America (five in the United
States of America [48, 51, 57, 62, 64], two in Canada
[27, 47]), three in Australia [55, 56, 58], two in New
Zealand [37, 63] and one in Singapore [33].
The interventions for CVD risk factors screening were
classified into five types based on their characteristics,
adapted from the classification by Jepson et al. [28]
whenever possible. These were: (1) physician reminder
(paper-based and computer-based reminder), (2) patient
invitation (letter and telephone invitation), (3) financial
incentives, (4) using dedicated personnel such as project
nurse and practice facilitator to help organize and/or
carry out screening, and (5) using a multifaceted
approach targeting both physicians and patients for
screening or using more than one measure to target a
population for screening. Physician reminder, patient
invitation and financial incentives for screening were
interventions that could influence provider or patient
behaviour directly or indirectly while using dedicated
personnel targeted at provider and organizational level.
Multifaceted approaches were targeted at either behav-
ioural or organizational level or both. Table 2 represents
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an overview of the characteristics of the included
studies. Details of the interventions, screening uptake
rates (for different risk factors and periods) and the
types of assessment are provided in Additional file 1.
Quality assessment of the studies included
Quality of methodology
The risk of bias for randomization was unclear and
low in 9 out of 10 of the randomized controlled
trials, except for one which was allocated high risk as
the randomization used odd or even numbers of the
last digit of the registration number – a process that
was not true randomization [60]. The risk of bias for
randomization was high for all non-randomized trials.
A description of allocation concealment was presented in
five (24%) studies [37, 49, 52, 59, 60]. Blinding of
participants and personnel was lacking in all studies
due to the nature of the interventions, which in-
volved the participants or health-care professionals
directly. The risk of bias for blinding of outcome as-
sessment was low in 13 (62%) studies as the out-
come measured in most studies was generated from
electronic record systems. One study was found to
have a high risk of bias for risk of incomplete out-
come data: data from two practices could not be
extracted and analyzed [49]. For reporting bias, low
risk of bias was found in all studies except the study
by Frank et al. where it was unclear [55]. For other
biases, the validity of one of the studies needed to
be interpreted with caution as one of the authors
was related to the company that programmed the
trial software [60]. The proportion of studies with
low, unclear and high risk of bias is presented in
Fig. 2. The summary of risk of bias for individual
studies is provided in Additional file 2.
Quality of intervention: description and replication
Most studies were clear in the descriptions of the inter-
ventions. Two studies lacked descriptions of the education
and training materials [33, 53]. Another two studies were
unclear on whether training and feedback were provided
to the groups [27, 56]. Details of the descriptions of the
interventions are provided in Additional file 3.
Overall effect of interventions compared with controls
Based on the pooled estimate of the effects of interven-
tions, in both optimistic and pessimistic analyses, the
CVD risk factors screening uptake rate was higher in the
intervention groups compared with the controls. The RR
was 1.443 (95% CI 1.264 to 1.648) using the pessimistic
estimate and 1.680 (95% CI 1.420 to 1.988) using the
optimistic estimate (refer to Fig. 3a & b).
Subgroup analyses
Effects of study designs
The quality of studies differed with different study
designs. Therefore, we pooled data according to study
designs i.e. RCT, non-randomized with controlled group
and pre- and post-studies (refer to Fig. 4a & b).
Fig. 1 Flow chart of the study search and selection
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Of the ten studies in the randomized/cluster randomized
controlled trials, four studies had three arms of interven-
tions [27, 37, 47, 48], one study had two arms of interven-
tions [49] and others had one arm of intervention. The
majority of the studies showed positive effects from the
interventions. Two studies, Grunfeld et al. and Apkon
et al., reported more than one effect size, and the effects
varied from negative to positive effect when pessimistic and
optimistic analyses were performed respectively [27, 51].
However, the overall pooled estimate using both pessimistic
and optimistic analyses were positive with a RR of 1.383
(95% CI 1.240 to 1.543) and 1.448 (95% 1.271 to 1.649), re-
spectively (refer to Fig. 4a & b, subgroup 1).
All of the non-randomized trials with controlled
groups and the pre- and post-studies were significantly
in favour of the intervention, except for one study each
from both groups when the pessimistic analysis was
performed [55, 56]. One study from the pre- and post-
study remained ineffective even when an optimistic
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analysis was performed [56]. The pooled estimate of the
effect for non-randomized trials with controlled groups
in both pessimistic (RR 1.347; 95% CI 1.197 to 1.517)
and optimistic analyses (RR 1.647; 95% CI 1.301 to
2.087) were significantly in favour of the interventions.
For the pre- and post-studies the pooled estimate of the
effect was not significant in both pessimistic (RR 1.875;
95% CI 0.677 to 5.194) and optimistic analyses (RR
2.428; 95% CI 0.971 to 6.074) (refer to Fig. 4a & b, sub-
group 2 and 3).
There was significant heterogeneity between the
studies in all three groups of study designs. The I2 for
all were more than 90%.
Effects of types of interventions
Using physician reminders (RR 1.392; 95% CI 1.192 to
1.625 in pessimistic analysis and RR 1.471; 95% CI 1.304,
1.660 in optimistic analysis), providing financial incen-
tives (RR 1.462; 95% CI 1.068 to 2.000) and using dedi-
cated personnel (RR 1.510; 95% CI 1.014 to 2.247 in
Fig. 3 a Effect of interventions vs. controls (using lowest effect size as outcome measure). b Effect of interventions vs. controls (using highest
effect size as outcome measure)
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pessimistic analysis and 2.536; 95% CI 1.297 to 4.960 in
optimistic analysis) for screening significantly increased
the uptake of CVD risk factors screening, compared to
the controlled groups. Interventions using multifaceted
approaches were effective when optimistic analysis was
performed (RR 2.268; 95% CI 1.401, 3.672) but not when
pessimistic analysis was performed (RR 1.549; 95% CI
0.978, 2.453). Patient invitations were not effective in
increasing the uptake of CVD risk factors screening
(RR1.285; 95% CI 0.980, 1.686) (refer to Fig. 5a & b).
In the intervention using physician reminders, six studies
used computer-based screen alert system reminders [47,
49, 51, 54, 55, 60], and two studies used paper-based re-
minders [48, 57]. One study used two approaches, one arm
used computer-based screen alert system reminders while
in the other arm, physicians were reminded when patients
handed the completed diabetes risk self-assessment forms
to them [37]. All studies were significantly in favour of the
intervention [37, 47–49, 54, 57, 60] except for two [51, 55].
A study by Frank et al. showed a significant positive effect
Fig. 4 a Effect of interventions vs. controls according to study designs (using lowest effect size as outcome measure). b Effect of interventions vs.
controls according to study designs (using highest effect size as outcome measure)
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in the optimistic analysis but not in the pessimistic analysis
[55]. A study by Apkon et al. showed effects were not sig-
nificant in both optimistic and pessimistic analyses [51].
(refer to Fig. 5a & b, Subgroup 1).
In the interventions using financial incentives for
screening, all studies [59, 62] were significantly in favour
of the intervention except for the study by Stocks et al.
[58]. Stocks et al. used shopping vouchers as rewards for
screening while the other two studies offered free or
subsidized screening as the intervention (refer to Fig. 5a
& b, Subgroup 3).
All three studies that used dedicated personnel as the
intervention to increase screening uptake were con-
ducted at clinics [27, 50, 61]. Two studies used dedicated
personnel (project nurse and health promotion nurse) to
deliver the screening [50, 61]. Their tasks were to invite,
follow-up and deliver the preventive care service. One
study used two different approaches; one used dedicated
Fig. 5 a Effect of types of interventions vs. controls (using lowest effect size as outcome measure). b Effect of types of interventions vs. controls
(using highest effect size as outcome measure)
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personnel to deliver the screening while the other used a
practice facilitator to help the organization improve the
system and implement changes for better care [27]. The
first two studies that used dedicated personnel to deliver
screening showed positive effects in both optimistic and
pessimistic analysis [50, 61]. The third study that used
dedicated personnel to deliver screening was effective in
the optimistic analysis; however, using dedicated
personnel targeted at the organizational level was not
[27] (refer to Fig. 5a & b, Subgroup 4).
The multifaceted approach was shown to be effective
in increasing the screening uptake in the optimistic
analysis (RR 2.268; 95% CI 1.401 to 3.672) but not in the
pessimistic analysis (RR 1.549; 95% CI 0.978 to 2.453)
(refer to Fig. 5a & b, Subgroup 5). There were only two
studies that used patient invitations to increase uptake
of CVD risk factors screening. The trend was towards a
positive effect but it was not significant (RR 1.285; 95%
CI 0.980 to 1.686) (refer to Fig. 5a & b, Subgroup 2).
All 21 studies were conducted in primary care settings
except for one study from Singapore that was conducted
in a housing estate. We have included this community
study in the analysis as the objective of this review was
to determine the effectiveness of intervention strategies
carried out in primary care settings or the community.
Removal of this study from the analysis did not alter the
effect size nor the statistical significance, although there
were magnitude changes in the estimates and CI (refer
to Additional file 4 for comparison of the effect size by
including and excluding this study in the analysis).
Meta-regression analysis showed that the effect size of
CVD risk factors screening uptake was not associated
with study designs, types of population and types of in-
terventions in both optimistic and pessimistic analyses.
Discussion
Summary of principal findings
We set out to determine the effectiveness of interven-
tions aimed to increase uptake of CVD risk factors
screening. Overall, our results showed that the interven-
tions were effective in increasing CVD risk factors
screening uptake. This effect size of the uptake was not
associated with the study design, types of population nor
types of interventions. Effective interventions that in-
creased screening participation included: using physician
reminders, use of dedicated personnel to deliver screen-
ing and providing financial incentives for screening.
Multifaceted approaches were effective when optimistic
analysis was performed.
Interpretation of the findings and comparison with
previous findings
We obtained 21 articles for analysis of which 9 were the
results from the initial search and 16 were from the
forward and backward bibliography and citation checks
of the search. The cross checking of bibliographies and
citations led to increased yield. This was especially true
when an article was cited in a review paper; by going
through the studies included in the review paper, we
found more papers relevant to our study. Thus, the back
and forth citation search could be a better way of track-
ing relevant articles.
Our results showed that studies with lower quality
(pre- and post-studies) had larger effect size (RR ranged
from 1.875 to 2.428) but lower precision compared with
studies with higher quality such as the non-randomized
trials with controlled groups (RR ranged from 1.347 to
1.647) and randomized controlled trials (RR ranged from
1.383 to 1.448). This is expected as studies with better
methodology had lower effect size but higher precision,
which was consistent with the literature and suggested
quality assessment of papers was useful [66].
The heterogeneity observed was significant and high
for all the meta-analyses performed. This was expected
given the diverse population, settings, study designs, in-
terventions and risk factors measured [66, 67]. Despite
this, the results for study effects were robust in one dir-
ection (refer to Figs. 3a & b, 4a & b, and 5a & b). This
implied that the results could possibly be generalized to
various populations [66].
The meta-regression was performed to explore whether
the differences in study designs, type of populations and
types of intervention could explain the heterogeneity seen
in the meta-analysis. Meta-regression is used to explore
associations between study-level features and the outcome.
For example, the quality of study design can result in arte-
factual variation. There may also be true differences in
effects arising from associations with differences in study
population (for instance variation in disease severity) or
intervention. Such effect modification may help identify
participants for whom the intervention is likely to produce
benefit [46]. In this meta-regression analysis, it was found
that study designs, types of population and types of inter-
vention did not influence the effect size.
The risk factors targeted for screening were heterogenous
and ranged from single to multiple CVD risk factors. There
were also interventions that involved other preventive
services such as vaccination. By performing two sets of
meta-analysis on the highest and lowest uptake rate for
each intervention, a range of effect size was provided to
clearly demonstrate the effectiveness of interventions across
various risk factors.
We found using physician reminders, dedicated
personnel or financial incentives for screening were ef-
fective interventions. Our study extends the evidence
from the previous systematic review by Jepson et al.,
where the types of interventions previously found to
be effective in cancer screening seem to have similar
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effects in CVD risk factors screening [28]. This sug-
gests that people’s health behaviour towards interven-
tions to improve screening was similar regardless of
the condition they had.
Although using physician reminders can increase CVD
risk factors screening uptake rate, its effect is limited to
patients attending the clinic for other reasons. For inter-
ventions using financial incentives to improve screening
uptake rates, our result was consistent with the results
of Jepson’s review [28]. Both reviews showed that inter-
ventions using reduced cost or free screening increased
uptake but not those providing incentives such as shop-
ping vouchers, gifts or transportation incentives. The
effect of free or subsidized screening is likely to be dif-
ferent depending on the way in which health services are
funded. When free screening is provided by existing
health-care systems, added rewards do not provide a fur-
ther effect on the uptake of screening [58].
Dedicated personnel can be used to deliver the screening
or to facilitate screening uptake at organizational level. This
review found that using dedicated personnel to deliver the
screening was effective in increasing CVD risk factors
screening uptake; the effect was uncertain for using dedi-
cated personnel targeted at the organizational level as there
was only one study researching this intervention. The use
of dedicated personnel (non-physician providers) to
increase preventive activities has been shown to be effective
in previous literature for adult immunization and cancer
screening [68, 69]. This intervention requires system
resources and support such as organisational change in
staffing and clinical procedures. Although using dedicated
personnel at organizational level such as practice facilitator
has been shown to be effective in improving the use of
evidence-based guideline in primary care and preventive
care performance [70, 71], the intervention did not consist-
ently show positive results in other studies [27, 72]. This
highlights the challenge in the implementation of this inter-
vention which may vary from practice to practice.
For intervention using a multifaceted approach, our
results shown inconsistent results in the effectiveness of
this intervention. The intervention was effective in opti-
mistic analysis but not when a pessimistic model was
used. A systematic review by Jepson et al. reported some
evidence in the effectiveness of multiple interventions
aimed at individuals or physicians and interventions
aimed at both physicians and individuals in increasing
screening uptake [28]. Further studies are needed to
confirm the effectiveness of multifaceted approaches in
increasing the uptake of CVD risk factors screening.
In contrast with other reviews for breast, cervical and
colorectal cancer screening [73–75], an invitation to
patients either by telephone or letter did not show a
significant effect in increasing CVD risk factors screening
uptake, although a positive trend was observed. Due to
the small samples (two studies and three comparisons), it
is difficult to conclude the effectiveness of this interven-
tion for CVD risks factor screening. With the global use
of information technology with mobile phones, telephone
invitation could be used as a mode for such invitations.
There was an increased use of mobile text messages that
have been shown to be effective in delivering reminders
for adherence to treatment and appointments in health-
care services [76]. Thus, mobile text messages might be
useful as a mode of invitation for screening. However, we
did not find any study using this mode as an intervention
for CVD risk factors screening.
Implications for policy and practice
Our results show that active recruitment targeted at any
level, either individual, health-care professional, or health-
care system were effective in increasing CVD risk factors
screening uptake. However, the intervention one chooses
would depend on the practice resources and support and
the target of coverage within a set time frame. For
example, physician reminders would not be applicable to
individuals who did not attend the clinic, and they could
potentially be the most at risk group. Provision of free
screening can be effective in health-care systems where
participants have to pay for screening. Using dedicated
personnel to deliver screening was effective, but the cost
and human resources demand would be high.
Strengths and weaknesses of this review
Our review has included both randomized and non-
randomized controlled trials as well as pre-and post-studies
interventions to provide more comprehensive views of
various interventions aimed to increase the uptake of CVD
risk factors screening. We believe that each of these studies
can contribute useful information to the review. Although
the non-randomized and non-controlled trials could inflate
the effect size of the interventions, the meta-regression we
performed did not show any significant association between
study designs and the effect size of the CVD risk factors
screening uptake.
There are several limitations in this review. At study
level, there was a high risk of bias for blinding of partici-
pants and personnel in all the studies. However, this was
unavoidable due to the nature of the interventions. At
review level, we have employed an extensive search
strategy. However, we limited it to publications in the
English language, due to limited resources. Hence, the
analysis should be treated with caution. In addition, we
did not identify any unpublished trials; thus publication
bias could not be examined. Other interventions such as
providing incentives to health practices might be useful,
but we could not find any of such studies.
We did not include cost-effectiveness of interventions
in this review which is an important area to look into
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when choosing an intervention. This will be a useful area
to explore in future reviews.
Conclusion
Physician reminders and providing financial incentives
were effective in influencing the provider’s and patient’s
behaviour to increase CVD risk factors screening uptake.
At organizational level, using dedicated personnel to de-
liver the screening was found to be effective.
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